Importance of 5-FU-based adjuvant Chemotherapy after preoperative Radio Chemo Threapy in locally advanced Rectal Cancer 10-Year results of the EORTC-22921-Study

被引：1
|
作者：
Guckenberger, Matthias [1 ]
机构：
[1] Univ Hosp Zurich USZ, Dept Radiat Oncol, CH-8091 Zurich, Switzerland
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷 / 08期
关键词：
PHASE-III TRIAL; POSTOPERATIVE CHEMORADIOTHERAPY; COLON; CAO/ARO/AIO-94; FLUOROURACIL; OXALIPLATIN; SURVIVAL; THERAPY;
D O I：
10.1007/s00066-014-0699-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：772 / 773
页数：2
相关论文
共 40 条
  • [11] Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison
    Diefenhardt, M.
    Kosmala, R.
    Fleischmann, M.
    Martin, D.
    Hofheinz, R. D.
    Ghadimi, M.
    Roedel, C.
    Polat, B.
    Fokas, E.
    ESMO OPEN, 2025, 10 (03)
  • [12] Neoadjuvant chemotherapy followed by neoadjuvant concurrent chemoradiation for locally advanced breast cancer: a feasibility study and 10-year follow-up results
    Kunheri, Beena
    Kottarathil, Vijaykumar Dehannathparambil
    Makuny, Dinesh
    Keechilat, Pavithran
    Padmanabhan, T. K.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 14 (04)
  • [13] Neoadjuvant chemotherapy followed by neoadjuvant concurrent chemoradiation for locally advanced breast cancer: a feasibility study and 10-year follow-up results
    Beena Kunheri
    Vijaykumar Dehannathparambil Kottarathil
    Dinesh Makuny
    Pavithran Keechilat
    T.K. Padmanabhan
    Indian Journal of Gynecologic Oncology, 2016, 14 (4)
  • [14] Complications, continence and quality of life after an intensive preoperative radio-chemotherapy regimen for locally advanced rectal cancer: analysis of a phase I–II study
    S. Pucciarelli
    E. Urso
    S. Serpentini
    P. Toppan
    G. L. De Salvo
    G. Fabris
    M. L. Friso
    C. Aschele
    A. Bruttocao
    M. Lise
    Annals of Surgical Oncology, 2004, 11 : S113 - S113
  • [15] Predictive value of Ki67 and p53 in locally advanced rectal cancer: Correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy
    Jakob, Christiane
    Liersch, Torsten
    Meyer, Wolfdietrich
    Becker, Heinz
    Baretton, Gustavo B.
    Aust, Daniela E.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (07) : 1060 - 1066
  • [16] Predictive value of Ki67 and p53 in locally advanced rectal cancer:Correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy
    Christiane Jakob
    Torsten Liersch
    Wolfdietrich Meyer
    Heinz Becker
    Gustavo B Baretton
    Daniela E Aust
    World Journal of Gastroenterology, 2008, (07) : 1060 - 1066
  • [17] Complications, continence and quality of life after an intensive preoperative radio-chemotherapy regimen for locally advanced rectal cancer: Analysis of a phase I-II study
    Pucciarelli, S
    Urso, E
    Serpentini, S
    Toppan, P
    De Salvo, GL
    Fabris, G
    Friso, ML
    Aschele, C
    Bruttocao, A
    Lise, M
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S113 - S113
  • [18] Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemo-radiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial
    Hofheinz, R-D
    Wenz, F.
    Post, S.
    Matzdorff, A.
    Laechelt, S.
    Hartmann, J. T.
    Mueller, L.
    Link, H.
    Moehler, M.
    Kettner, E.
    Fritz, E.
    Hieber, U.
    Lindemann, H. W.
    Grunewald, M.
    Kremers, S.
    Constantin, C.
    Hipp, M.
    Gencer, D.
    Burkholder, I
    Hochhaus, A.
    ONKOLOGIE, 2011, 34 : 199 - 199
  • [19] 5-FU-docetaxel and concurrent radiation as salvage therapy after failure of neo-adjuvant chemotherapy for locally advanced primary breast cancer: a feasibility study
    Berger, A
    Chambeau-Ferru, A
    Chieze, S
    Coulaud-Pasdeloup, F
    Chabrun, V
    Gaci, Z
    Daban, A
    Bourgeois, H
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S253 - S253
  • [20] 5-FU-docetaxel and concurrent radiation as salvage therapy after failure of neo-adjuvant chemotherapy for locally advanced primary breast cancer: a faisability study.
    Berger, A
    Chambeau-Ferru, A
    Chieze, S
    Coulaud-Pasdeloup, F
    Chabrun, V
    Gaci, Z
    Daban, A
    Bourgeois, H
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S39 - S40
1234